<DOC>
	<DOCNO>NCT00370760</DOCNO>
	<brief_summary>To evaluate efficacy oral colchicine combine intraoperative infusion dexamethasone , low molecular weight heparin 5-FU vitrectomy management establish proliferative vitreoretinopathy ( PVR )</brief_summary>
	<brief_title>Oral Colchicine Combined With Intravitreal Infusion Dexamethasone , LMW Heparin 5-FU Management Proliferative Vitreoretinopathy ( PVR )</brief_title>
	<detailed_description />
	<mesh_term>Vitreoretinopathy , Proliferative</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Colchicine</mesh_term>
	<mesh_term>Calcium heparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>Cases rhegmatogenous retinal detachment complicate PVR grade C History par plana vitrectomy PVR grade C History silicone oil injection History ocular trauma Diabetic retinopathy Glaucoma Giant retinal tear</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>PVR</keyword>
	<keyword>Oral colchicine</keyword>
	<keyword>Dexamethasone</keyword>
	<keyword>low molecular weight heparin</keyword>
	<keyword>5-FU</keyword>
</DOC>